Folgen
Giada Sebastiani
Giada Sebastiani
Professor of Medicine, McGill University
Bestätigte E-Mail-Adresse bei mcgill.ca - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta‐analysis
PS Dulai, S Singh, J Patel, M Soni, LJ Prokop, Z Younossi, G Sebastiani, ...
Hepatology 65 (5), 1557-1565, 2017
16442017
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10432019
Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis
RS Taylor, RJ Taylor, S Bayliss, H Hagström, P Nasr, JM Schattenberg, ...
Gastroenterology 158 (6), 1611-1625. e12, 2020
7162020
Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy
G Sebastiani, A Alberti
World journal of gastroenterology: WJG 12 (23), 3682, 2006
3612006
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C
G Sebastiani, A Vario, M Guido, F Noventa, M Plebani, R Pistis, A Ferrari, ...
Journal of hepatology 44 (4), 686-693, 2006
3562006
Chronic hepatitis C and liver fibrosis
G Sebastiani, K Gkouvatsos, K Pantopoulos
World journal of gastroenterology: WJG 20 (32), 11033, 2014
3102014
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C
L Castéra, G Sebastiani, B Le Bail, V de Lédinghen, P Couzigou, A Alberti
Journal of hepatology 52 (2), 191-198, 2010
2932010
SAFE biopsy: a validated method for large‐scale staging of liver fibrosis in chronic hepatitis C
G Sebastiani, P Halfon, L Castera, S Pol, DL Thomas, A Mangia, ...
Hepatology 49 (6), 1821-1827, 2009
2332009
Liver fibrosis: Review of current imaging and MRI quantification techniques
L Petitclerc, G Sebastiani, G Gilbert, G Cloutier, A Tang
Journal of Magnetic Resonance Imaging 45 (5), 1276-1295, 2017
2162017
Limitations of non-invasive tests for assessment of liver fibrosis
K Patel, G Sebastiani
JHEP Reports 2 (2), 100067, 2020
2032020
Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B
G Sebastiani, A Vario, M Guido, A Alberti
World journal of gastroenterology: WJG 13 (4), 525, 2007
1952007
Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study
G Sebastiani, D Tempesta, G Fattovich, L Castera, P Halfon, M Bourliere, ...
Journal of hepatology 53 (4), 630-638, 2010
1842010
Global multi-stakeholder endorsement of the MAFLD definition
N Méndez-Sánchez, E Bugianesi, RG Gish, F Lammert, H Tilg, ...
The lancet Gastroenterology & hepatology 7 (5), 388-390, 2022
1602022
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0
L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ...
HIV medicine 21 (10), 617-624, 2020
1542020
The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases
G Sebastiani, L Castera, P Halfon, S Pol, A Mangia, V Di Marco, M Pirisi, ...
Alimentary pharmacology & therapeutics 34 (10), 1202-1216, 2011
1462011
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis
S Petta, G Sebastiani, E Bugianesi, M Viganò, VWS Wong, A Berzigotti, ...
Journal of hepatology 69 (4), 878-885, 2018
1312018
A seven‐gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C
M Marcolongo, B Young, F Dal Pero, G Fattovich, L Peraro, M Guido, ...
Hepatology 50 (4), 1038-1044, 2009
1302009
Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms
G Sebastiani
World journal of gastroenterology: WJG 15 (18), 2190, 2009
1212009
Incidence and predictors of nonalcoholic fatty liver disease by serum biomarkers in patients with inflammatory bowel disease
T Bessissow, NH Le, K Rollet, W Afif, A Bitton, G Sebastiani
Inflammatory bowel diseases 22 (8), 1937-1944, 2016
1202016
Pharmacological targeting of the hepcidin/ferroportin axis
G Sebastiani, N Wilkinson, K Pantopoulos
Frontiers in pharmacology 7, 206109, 2016
1112016
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20